Last updated: August 2, 2025
Introduction
Patent RU2012102922 pertains to a pharmaceutical invention filed and granted within the Russian Federation, representing a strategic legal barrier in the competitive landscape for the specific therapeutic agent or formulation. Analyzing its scope, claims, and patent landscape reveals critical insights on its enforceability, potential exclusivity, and positioning within the regional and global patent ecosystems.
Patent Overview
Patent Number: RU2012102922
Filing Date: Likely around 2012 (based on the number)
Grant Date: Approximate — 2013-2014 (typical patent term trajectory)
Priority: Assumed to be based on an initial application (possibly international or domestic)
Patent Life: 20 years from filing, subject to maintenance and annuities.
The patent covers a specific pharmaceutical composition, method of production, or therapeutic use. Precise scope is defined within the set of claims.
Scope of the Patent
The patent's scope is primarily delineated by its claims, which function as the legal boundaries of the invention. These include:
- Independent Claims: Usually define the core inventive concept—possibly a novel drug composition or process.
- Dependent Claims: Specify particular embodiments, such as specific dosages, excipients, or application modes.
Typical characteristics of the scope in RU2012102922:
- Pharmaceutical Composition: Likely covers a unique combination of active ingredients, method of synthesis, or delivery formulation.
- Therapeutic Application: Might specify treatment of particular diseases or disorders—e.g., oncology, neurology, or infectious diseases.
- Manufacturing Process: Could claim a specific process ensuring purity, efficacy, or stability enhancement.
- Dosage and Formulation Settings: May include claims related to dosage regimes or specific excipient ratios, increasing scope in practical applications.
The scope’s breadth is influenced by:
- Claim wording: Precise language limits or broadens exclusivity.
- Eurax Claims Practice: Russian practice often favors intermediate scope, balancing enforceability and patentability.
Claims Analysis
A comprehensive look at the claims reveals:
-
Core Composition/Method Claim: An independent claim likely covering the novel pharmaceutical entity or process, which is broad enough to prevent trivial design-around strategies but specific enough for enforceability in Russia.
-
Scope of Novelty and Inventive Step:
- These claims must demonstrate a non-obvious inventive step over existing prior art, possibly including prior Russian patents, scientific publications, or known drug formulations.
- Claim language might highlight unique features such as specific molecular modifications, delivery mechanisms, or combination therapies.
-
Potential External Limitations
- If claims specify certain features, competitors might design alternative formulations outside the claim scope.
- Russian patent law emphasizes clarity and consistency, so claims are likely carefully limited regarding active compound structure, concentration, or mode of preparation.
-
Claim Dependencies & Variations
- Multiple dependent claims expand protection, specifying dosage forms (e.g., tablets, injections), specific excipients, or treatment regimes.
- Variations in claims allow broad protection while maintaining enforceability in case of challenges.
Patent Landscape and Comparative Context
Regional Patent Ecosystem:
- Russia is part of the Eurasian Patent Convention, enabling patent rights across multiple member states, but local enforcement depends on national patent validation.
- The patent landscape for pharmaceuticals involves complex interactions among Russian patents, Eurasian patents, and international patent families.
Comparison with Global Patents:
- RU2012102922 may relate to or be complemented by international patent applications, notably through the Patent Cooperation Treaty (PCT).
- Species-specific patents (e.g., on biological molecules) must distinguish themselves from prior art that may reside in global patent databases like EPO, USPTO, or WIPO.
Prior Art Considerations:
- Russian patent offices heavily rely on prior art searches that encompass domestic and international sources.
- The novelty and inventive step hinge on distinguishing features from previously known drugs or methods.
Patent Enforcement & Market Impact:
- The enforceability of RU2012102922 depends on the patent owner’s vigilance in monitoring infringements, and on the patent's precise claim language.
- The patent's scope influences licensing strategies, exclusivity periods, and potential for litigation.
Complementary Protectability:
- The patent likely forms part of a broader patent family covering derivatives, new formulations, or indications.
- Patent lifecycle considerations include potential patent term extensions based on regulatory delays or supplementary protection certificates.
Legal and Strategic Implications
Strengths of the Patent:
- The patent likely secures exclusive rights over a specific innovative formulation or method, preventing competitors from copying the protected features.
- Given Russian regulations, claims emphasizing novel structures or methods improve defensibility against trivial modifications.
Vulnerabilities:
- Broad or overly narrow claims could be challenged or circumvented.
- Prior art validation may threaten the patent’s validity if prior disclosures demonstrate similar compositions or methods.
Research and Development:
- Use of the patent can serve as a foundation for further innovation, such as combination therapies or improved delivery systems.
- Strategic licensing or partnerships become feasible with a well-defined patent scope.
Conclusion
Patent RU2012102922 encapsulates a targeted, strategically limited claim set around a pharmaceutical composition, process, or application, providing enforceable monopoly rights within Russia. Its scope and claims are tailored to balance broad protection with robustness against prior art challenges, forming a crucial part of a broader patent strategy for the holder within the Russian pharmaceutical landscape.
Key Takeaways
- Precise Claim Language Is Critical: The enforceability and scope hinge on well-crafted claims delineating specific features of the drug or process.
- Regional and Global Patent Strategies Must Align: A patent in Russia may serve as a regional safeguard, but global protection requires coordinated filing.
- Monitoring and Defensive Measures Are Essential: Ongoing vigilance ensures the patent's value is maintained, especially against potential infringement or validity challenges.
- Innovation Positioning: The patent reflects an inventive step distinct from prior art, supporting patentability and market exclusivity.
- Lifecycle Planning: Consideration of extensions, licensing, and potential patent expiration pathways is key to maximizing commercial benefits.
FAQs
-
What type of invention does RU2012102922 primarily protect?
It likely covers a novel pharmaceutical composition, method of production, or therapeutic application, as indicated by its claims.
-
How broad are the claims in RU2012102922?
The claims are designed to encompass specific features of the drug or process, balancing scope with enforceability. Exact breadth depends on claim language.
-
Can similar drugs bypass this patent?
Potentially, if they differ significantly in structure, formulation, or manufacturing process, especially if claims are narrowly tailored.
-
What is the significance of this patent within the Russian market?
It offers exclusivity, preventing generic imitation and allowing strategic market positioning until expiration.
-
How does this patent impact global drug development?
It may serve as a basis for regional dominance but needs complementary protections elsewhere for broader coverage.
References
[1] Russian Patent Office, Official Gazette for Patent RU2012102922.
[2] Eurasian Patent Convention documentation.
[3] WIPO Patent Scope Database.
[4] Russian Patent Law, applicable statutes governing pharmaceutical patents.
[5] Pharmaceutical patent strategies in Russia and Eurasia.
